MedDx Solutions Limited - Accounts to registrar (filleted) - small 18.2

MedDx Solutions Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.2.0.376 08688185 Board of Directors 1.1.20 31.12.20 31.12.20 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure086881852019-12-31086881852020-12-31086881852020-01-012020-12-31086881852018-12-31086881852019-01-012019-12-31086881852019-12-3108688185ns16:EnglandWales2020-01-012020-12-3108688185ns15:PoundSterling2020-01-012020-12-3108688185ns11:Director12020-01-012020-12-3108688185ns11:PrivateLimitedCompanyLtd2020-01-012020-12-3108688185ns11:SmallEntities2020-01-012020-12-3108688185ns11:AuditExempt-NoAccountantsReport2020-01-012020-12-3108688185ns11:SmallCompaniesRegimeForDirectorsReport2020-01-012020-12-3108688185ns11:SmallCompaniesRegimeForAccounts2020-01-012020-12-3108688185ns11:AbridgedAccounts2020-01-012020-12-310868818512020-01-012020-12-3108688185ns11:Director22020-01-012020-12-3108688185ns11:Director32020-01-012020-12-3108688185ns11:RegisteredOffice2020-01-012020-12-3108688185ns6:CurrentFinancialInstruments2020-12-3108688185ns6:CurrentFinancialInstruments2019-12-3108688185ns6:Non-currentFinancialInstruments2020-12-3108688185ns6:Non-currentFinancialInstruments2019-12-3108688185ns6:ShareCapital2020-12-3108688185ns6:ShareCapital2019-12-3108688185ns6:CapitalRedemptionReserve2020-12-3108688185ns6:CapitalRedemptionReserve2019-12-3108688185ns6:RetainedEarningsAccumulatedLosses2020-12-3108688185ns6:RetainedEarningsAccumulatedLosses2019-12-3108688185ns6:PatentsTrademarksLicencesConcessionsSimilar2020-01-012020-12-3108688185ns6:LeaseholdImprovements2020-01-012020-12-3108688185ns6:PlantMachinery2020-01-012020-12-3108688185ns6:FurnitureFittings2020-01-012020-12-3108688185ns6:MotorVehicles2020-01-012020-12-3108688185ns6:CurrentFinancialInstrumentsns6:HirePurchaseContractsns6:WithinOneYear2020-12-3108688185ns6:CurrentFinancialInstrumentsns6:HirePurchaseContractsns6:WithinOneYear2019-12-3108688185ns6:HirePurchaseContractsns6:BetweenOneFiveYears2020-12-3108688185ns6:HirePurchaseContractsns6:BetweenOneFiveYears2019-12-3108688185ns6:HirePurchaseContracts2020-12-3108688185ns6:HirePurchaseContracts2019-12-3108688185ns6:WithinOneYear2020-12-3108688185ns6:WithinOneYear2019-12-3108688185ns6:BetweenOneFiveYears2020-12-3108688185ns6:BetweenOneFiveYears2019-12-3108688185ns6:MoreThanFiveYears2020-12-3108688185ns6:MoreThanFiveYears2019-12-3108688185ns6:AllPeriods2020-12-3108688185ns6:AllPeriods2019-12-31
REGISTERED NUMBER: 08688185 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2020

for

MedDx Solutions Limited

MedDx Solutions Limited (Registered number: 08688185)

Contents of the Financial Statements
for the year ended 31 December 2020










Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


MedDx Solutions Limited

Company Information
for the year ended 31 December 2020







Directors: R J Senior
R I Davidson
E A Madden





Registered office: Unit 3, Skylon Place
Hursey Road
Rotherwas
Hereford
HR2 6NX





Registered number: 08688185 (England and Wales)





Accountants: Acre Accountancy Limited
Unit 2 Foley Works
Foley Industrial Estate
Hereford
Herefordshire
HR1 2SF

MedDx Solutions Limited (Registered number: 08688185)

Abridged Balance Sheet
31 December 2020

2020 2019
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 60,878 69,578
Tangible assets 5 278,631 159,780
339,509 229,358

CURRENT ASSETS
Stocks 458,399 156,148
Debtors 14,306,820 118,007
Cash at bank and in hand 12,025,228 515,184
26,790,447 789,339
CREDITORS
Amounts falling due within one year 23,138,231 418,911
NET CURRENT ASSETS 3,652,216 370,428
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,991,725

599,786

CREDITORS
Amounts falling due after more than one
year

-

(358,125

)

PROVISIONS FOR LIABILITIES (48,977 ) (24,657 )
NET ASSETS 3,942,748 217,004

CAPITAL AND RESERVES
Called up share capital 196 300
Capital redemption reserve 104 -
Retained earnings 3,942,448 216,704
SHAREHOLDERS' FUNDS 3,942,748 217,004

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2020.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2020 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MedDx Solutions Limited (Registered number: 08688185)

Abridged Balance Sheet - continued
31 December 2020


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 December 2020 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 August 2021 and were signed on its behalf by:





R J Senior - Director


MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements
for the year ended 31 December 2020


1. STATUTORY INFORMATION

MedDx Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is recognised at the fair value of the consideration received or receivable for sales of good and services in the ordinary course of the business. Turnover is shown net of Value Added Tax, for goods and services provided to customers.

Intangible assets - patents
Costs incurred in acquiring or developing patent rights are capitalised where the directors consider that the company will benefit from the use of the patent rights. At each accounting period the directors consider whether there has been any impairment in the value of such patent rights. Where the directors consider that the value of patent rights reduces over time, the directors amortise the value on a straight line basis over the useful economic life of the asset. In 2016 the company commenced the amortisation of patent costs over the useful economic life of 12 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - Over the period of the lease
Plant and machinery - at varying rates on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements - continued
for the year ended 31 December 2020


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Assets obtained under hire purchase and finance leases are capitalised as tangible assets and depreciated over their useful lives in accordance with depreciation policy. Obligations under such agreements are included in creditors net of the finance charge allocated to future periods. The finance element of the lease payments is charged to the profit and loss account over the period of the contract.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for according to the substance of the contractual arrangement. They are classified as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Government grants
Government grants, where revenue in nature, are recognised as income in the profit and loss account in the same period in which the related expenditure is recognised.

Grants related to assets are initially credited to a deferral account in creditors and are released to the profit and loss account as the related asset is depreciated.

The COVID-19 pandemic prompted a number of revenue grants that are intended to subsidise expenditure and losses incurred. These have been recognised as other operating income.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 29 (2019 - 14 ) .

4. INTANGIBLE FIXED ASSETS

Other intangible assets relates to the value of patent rights held by the company.

MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements - continued
for the year ended 31 December 2020


5. TANGIBLE FIXED ASSETS
Totals
£   
Cost
At 1 January 2020 407,767
Additions 181,450
At 31 December 2020 589,217
Depreciation
At 1 January 2020 247,987
Charge for year 62,599
At 31 December 2020 310,586
Net book value
At 31 December 2020 278,631
At 31 December 2019 159,780

6. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
2020 2019
£    £   
Net obligations repayable:
Within one year 13,125 17,500
Between one and five years - 13,125
13,125 30,625

Non-cancellable operating leases
2020 2019
£    £   
Within one year 93,776 42,540
Between one and five years 216,829 170,160
In more than five years 14,180 56,720
324,785 269,420

7. SECURED DEBTS

The following secured debts are included within creditors:

2020 2019
£    £   
Hire purchase contracts 13,125 30,625

Hire purchase debts are secured on certain fixed assets of the company.

MedDx Solutions Limited (Registered number: 08688185)

Notes to the Financial Statements - continued
for the year ended 31 December 2020


8. RELATED PARTY DISCLOSURES

The company was under the control of its directors, by virtue of their shareholdings (held directly or by other related parties).